Distant metastasis-free survival with pembrolizumab versus placebo as adjuvant therapy in stage IIB or IIC melanoma: the phase 3 KEYNOTE-716 study

被引：0

作者：

Long, G. V. ^{[1
,2
]}

Luke, J. ^{[3
]}

Khattak, M. A. ^{[4
,5
]}

de la Cruz Merino, L. ^{[6
]}

Del Vecchio, M. ^{[7
]}

Rutkowski, P. ^{[8
]}

Spagnolo, F. ^{[9
]}

Mackiewicz, J. ^{[10
,11
]}

Chiarion-Sileni, V. ^{[12
]}

Kirkwood, J. M. ^{[3
]}

Robert, C. ^{[13
,14
]}

Grob, J. J. ^{[15
]}

de Galitiis, F. ^{[16
]}

Schadendorf, D. ^{[17
,18
]}

Carlino, M. S. ^{[1
,19
]}

Wu, L. ^{[20
]}

Fukunaga-Kalabis, M. ^{[20
]}

Krepler, C. ^{[20
]}

Eggermont, A. M. M. ^{[21
,22
]}

Ascierto, P. A. ^{[23
]}

机构：

[1] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia

[2] Royal North Shore & Mater Hosp, Sydney, NSW, Australia

[3] UPMC Hillman Canc Ctr, Pittsburgh, PA USA

[4] Fiona Stanley Hosp, Perth, WA, Australia

[5] Edith Cowan Univ, Perth, WA, Australia

[6] Hosp Univ Virgen Macarena, Seville, Spain

[7] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[8] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland

[9] IRCCS San Martino Polyclin Hosp, Genoa, Italy

[10] Poznan Univ Med Sci, Poznan, Poland

[11] Greater Poland Canc Ctr, Poznan, Poland

[12] IOV IRCCS, Ist Oncol Veneto, Padua, Italy

[13] Inst Gustave Roussy, Villejuif, France

[14] Paris Saclay Univ, Villejuif, France

[15] Aix Marseille Univ, AP HM Hosp, Marseille, France

[16] Dermopath Inst Immaculate IDI IRCCS, Rome, Italy

[17] Univ Hosp Essen, Essen, Germany

[18] German Canc Consortium Partner Site, Essen, Germany

[19] Westmead & Blacktown Hosp, Sydney, NSW, Australia

[20] Merck & Co Inc, Kenilworth, NJ USA

[21] Univ Med Ctr Utrecht, Utrecht, Netherlands

[22] Princess Maxima Ctr, Utrecht, Netherlands

[23] Ist Nazl Tumori IRCCS Fdn Pascale, Naples, Italy

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2022年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

eP121

引用

页码：95 / 95

页数：1